Skip to main content
Acta Bio Medica : Atenei Parmensis logoLink to Acta Bio Medica : Atenei Parmensis
. 2021 Jul 1;92(3):e2021217. doi: 10.23750/abm.v92i3.11098

COVID-19 pandemic in an Italian obstetric Department: sharing our experience

Lorenza Driul 1, Francesco Meroi 2,, Fabiana Cecchini 1, Alessia Sala 1, Daniele Orso 2, Diana Padovani 1, Serena Rovida 3, Teresa Dogareschi 4, Luigi Vetrugno 2, Tiziana Bove 2
PMCID: PMC8343760  PMID: 34212913

Abstract

Background and aim of the work:

The outbreak of the novel coronavirus (or SARS-CoV 2) has struck the healthcare system worldwide. Within few weeks hospitals had to reorganize their internal logistics and structure covering any level of care, from the Emergency Room to medical Departments.

Methods:

Due to the state of medical emergency, the Gynecology and Obstetrics Unit of the University Hospital in Udine developed new protocols for the usual standard of care, ensuring a safe environment for both healthcare providers and patients.

Results:

By a continuous update of scientific evidence, the Department was able to increase capacity as well as maintain flexibility when an unexpected high number of admissions was required. 40 COVID -19 positive patients were admitted to our Department between March and December 2020, none of them had complications and no case of cross infection between patients and medical staff were registered.

Conclusion:

We aimed to share our experience, which provided a notable lesson about what to expect and how to prepare a high-risk pregnancy referral center in response to a pandemic. (www.actabiomedica.it)

Keywords: SARS-CoV 2, COVID-19, high-risk pregnancies, delivery, obstetric care, resources management

Introduction

The first case of a novel Coronavirus related disease (COVID-19) has been reported in mainland China, outside Hubei province last December (1). As of March 2020, more than 10.000 confirmed cases had been registered and the epidemic turned into a global pandemic according to the WHO. Among the western countries, Italy was hardly hit by the first pandemic wave earlier this year with the highest mortality rate in the northern regions. Although there is still no specific medical treatment for the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2), the lockdown measure appears to be the only and effective strategy to prevent the infection spread. In agreement with that, following the release of travel restrictions over the summer our nation saw another spike of infections by the end of September, which resulted in a current second pandemic wave.

The Italian Obstetric Surveillance System (ItOSS) provided data among the patients affected by SARS-CoV-2, including those patients infected during the pregnancy and postpartum. From February 25th to April 20th, a total of 146 obstetric women tested positive to COVID-19 in Italy, with an incidence in parturients of 2.1 per 1000 births. Obstetric patients are vulnerable to respiratory tract infections due to the physiological change of their pulmonary function and immune system. Cases of severe illness and adverse pregnancy outcomes associated with Severe Acute Respiratory Syndrome (SARS) and the Middle East respiratory syndrome (MERS) have been previously described in literature including miscarriage, premature delivery, intrauterine growth restriction, and maternal death (2,3). Despite the effect of COVID-19 in pregnancy is still unclear, from the first available data it appears to be less serious than the other virus belonging to the Coronaviridae family (3-5). A recent study reports a maternal mortality and admission to Intensive Care Unit risk rates of 0.8% and 11.8% respectively (6). For newborns, aspects such low birth weight, early gestational age at time of infection and maternal ventilatory support are related to increased complication in the perinatal age. There is also no evidence of viral vertical transmission neither in pregnancy nor within delivery (7). However, evidence of psychological and psychiatric disorder in the post partum period for the mothers is raising (8).

The Department of Gynecology and Obstetrics of the University Hospital of Udine works as a referral center for high-risk pregnancies, providing its service to the Friuli - Venezia Giulia region. (Figure 1)

Figure 1.

Figure 1.

Hub and spoke system of the referral center of the University Hospital of Udine. Distances in kilometers (km) and minutes (‘) to destination with an ambulance are shown in the diagram.

Every year the Department has 45.000 visits, 2.000 births, and performs 2.000 procedures of acute or elective surgery. Since the beginning of the pandemic the whole Unit, following national guidelines and internal protocols, has been transformed at different levels, including obstetrical triage, labor and delivery, recovery and inpatient postpartum settings. An entire dedicated COVID-19 wing has also been set up hosting up 6 rooms, each of them equipped with oxygen delivery devices.

We believe our experience can be translated into a lesson for the general medical community and particularly for the Obstetric Departments where infection prevention and control is crucial for both pregnant patients and newborns.

Triage for pregnant patients and newborns

Our Department is the main referral center for those patients with obstetric complications who need highly specialized care (9). The management of these patients is very specific and needs to be accurate (10, 11). Table 1 summarizes the most relevant papers on the subject.

Table 1.

Most relevant articles on COVID-19 and pregnancy.

Authors Title Journal Issue
Ferrazzi E.M. et al. COVID-19 Obstetrics Task Force, Lombardy, Italy: Executive management summary and short report of outcome Int J Gynaecol Obstet 2020 Jun;149(3):377-378
Chen Y et al. Maternal health care management during the outbreak of coronavirus disease 2019 J Med Virol 2020 Jul;92(7):731-739
López M et al. Coronavirus Disease 2019 in Pregnancy: A Clinical Management Protocol and Considerations for Practice Fetal Diagn Ther 2020;47(7):519-528
Fryer K. et al. Implementation of Obstetric Telehealth During COVID-19 and Beyond Matern Child Health J 2020 Sep;24(9):1104-1110
Stephens A.J. et al. General Guidelines in the Management of an Obstetrical Patient on the Labor and Delivery Unit during the COVID-19 Pandemic Am J Perinatol 2020 Jun;37(8):829-836
London V. et al. Caring for Pregnant Patients with COVID-19: Practical Tips Getting from Policy to Practice Am J Perinatol 2020 Jun;37(8):850-853
Aziz A. et al. Telehealth for High-Risk Pregnancies in the Setting of the COVID-19 Pandemic Am J Perinatol 2020 Jun;37(8):800-808
Alfieri N. et al. COVID-19 does not stop obstetrics: what we need to change to go on safely birthing. The experience of a University Obstetrics and Gynecology Department in Milan J Perinat Med 2020 Jul 7
Ashokka B. et al. Care of the pregnant woman with coronavirus disease 2019 in labor and delivery: anesthesia, emergency cesarean delivery, differential diagnosis in the acutely ill parturient, care of the newborn, and protection of the healthcare personnel Am J Obstet Gynecol 2020 Jul;223(1):66-74.e3
Kiely D.J. et al. Health Care Team Training and Simulation-Based Education in Obstetrics During the COVID-19 Pandemic J Obstet Gynaecol Can 2020 Aug;42(8):1017-1020
Jamieson D.J. et al. Obstetricians on the Coronavirus Disease 2019 (COVID-19) Front Lines and the Confusing World of Personal Protective Equipment Obstet Gynecol 2020 Jun;135(6):1257-1263
Wu B. et al. Strategic plan for the management of COVID-19 in an obstetrics Department Rev Assoc Med Bras 2020 Jul;66(7):890-893
Suzumori N. et al. Management strategy of pregnant women during COVID-19 pandemic Aust N Z J Obstet Gynaecol 2020 Aug;60(4):E9-E10
Qi H. et al. Management of a delivery suite during the COVID-19 epidemic Eur J Obstet Gynecol Reprod Biol 2020 Jul;250:250-252.
Trapani A.J. et al. Childbirth, Puerperium and Abortion Care Protocol during the COVID-19 Pandemic Rev Bras Ginecol Obstet 2020 Jun;42(6):349-355
Boelig R.C. et al. Labor and delivery guidance for COVID-19 Am J Obstet Gynecol MFM 2020 May;2(2):100110
Franchi M. et al. Management of obstetrics and gynecological patients with COVID-19. Italian JOG 2020 March Vol. 32 (No. 1), 6-19
WAPM Working Group on COVID-19 Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection. Ultrasound Obstet Gynecol. 2021 Feb;57(2):232-241

Since the very beginning of the pandemic, a midwife-led triage strategy at the Department front door has been implemented. This process consists of an algorithm summarized on a flow-chart which is weekly updated according to the latest scientific evidence and national guidance (Supplemental material). Each patient is considered suspected COVID-19 positive until proven otherwise. When an elective admission (e.g., induction of labor) is planned, a nasopharyngeal molecular swab test is taken in advance and if positive the day of hospitalization the women will follow a red path consisting of a dedicated and isolated rooms for induction and for delivery. If case the procedure is not urgent, it may be postponed. For those patients requiring an ambulatory urgent treatment, a rapid swab test on the site is performed before entering the Department. Since the virus concentration or RNA is higher in the early presymptomatic phase, an antigen-detecting rapid diagnostic (ag-RDT) test is preferred as first level screening as it provides results in 12 minutes ensuring a safe COVID free zone. If hospitalization is required an ag-RDT test is followed by a molecular PCR test even when the first swab is negative. The result is validated within two hours.

Control swabs on the third and seventh day of the hospitalization are also performed. In case of anticipated patient discharge from hospital, the second one could be anticipated on the fifth day from the admission.

With a negative COVID-19 rapid swab test, the patient can follow the non-COVID-19 route, which is the standard pathway in use before the pandemic outbreak. Confirmed positive or high suspicious cases at triage are taken into isolation rooms (Figure 2) and examined by health care providers covered by personal protective equipment. An ultrasound machine and the electronic fetal surveillance instruments are deep cleaned after their use.

Figure 2.

Figure 2.

A depiction of the isolated COVID-19 wing of the ward.

In case of labor, delivery or other obstetric emergencies, a dedicated lift and entry to the delivery room (Figure 3) is guaranteed as well as donning and doffing area and theatre.

Figure 3.

Figure 3.

A picture of the dedicated labor and delivery room for COVID-19 positive patients, with all the necessary equipment for mother and child.

After birth, placental and fetal membranes collection for microbiological and histological analysis is recommended. If the newborn does not require intensive care, the mother can meet him even if she tested positive to the swab. However, if the mother has severe respiratory symptoms, the newborn will be isolated and admitted to the Neonatal Intensive Care Unit till the mother’s negative swab. Fathers are allowed in the labor/delivery room following a negative swab, but visits are forbidden during the hospital stay.

Monitoring of the patient’s respiratory symptoms by Lung Ultrasound

The use of Lung Ultrasound (LU) during the pandemic spread among several specialties including Obstetricians and Gynecologists. Although the technique seems to be feasible even by doctors with minimal ultrasound background, a proper amount of training, scanning approach and sonography basics are mandatory (12). The benefits of LU are many, including low cost, reproducibility, and prompt monitoring along with the patient’s symptoms evolution (13-15). Moreover, since clinicians are performing bedside scans, no other hospital staff (porters, radiographers, and radiologists) has to be involved, saving time and containing the viral spread.

Overall, LU has proven its ability to diagnose pneumonia: accuracy ranges from 94% to 98% depending on the population settings (16-18). A standard LU protocol has been widely adopted by the medical community for COVID-19 patients consisting in the evaluation of 12 lung regions, 6 on each side. Each hemithorax has anterior, lateral, and posterior zones, (demarcated by the anterior and posterior axillary line) and further divided into superior and inferior fields by a horizontal line (19) (Figure 4).

Figure 4.

Figure 4.

The anterosuperior (1) anteroinferior (2) laterosuperior (3), and lateroinferior (4) quadrants for the LU protocol. The abdominal mass and the breast increase could limit the exam, especially in zone 2.

Typical findings described in COVID-19 patients are as follow: coalescent B lines, subpleural consolidations, pleural irregularity, and thickening (20). The “light beam” has also been reported as one of the main sonographic features (21), described as a shining band-form artifact spreading down from a large portion of a regular pleura often appearing and disappearing with an on-off effect in the context of a normal aerated lung pattern. Although not specific for COVID-19 infection, all these findings can raise the suspicion of infection even in absence of nasopharyngeal swab results (22). A remarkable aspect is that LU abnormalities can be detected prior to the presentation of the symptoms, guiding the decision-making process of the clinicians at front door triage (23).

A LU score (LUS) proposed by some Authors allows serial lung aeration assessments supporting the decision to escalate patient’s medical care (24,25). Each of the 12 lung zones is scanned and scored from 1 to 3 according to the findings. Zero is assigned in presence of A-lines and pleural sliding, or ≤2 B-lines; 1 point is for more or equal to 3 well-spaced B-lines (interstitial syndrome); 2 points are calculated for coalescent B-lines or “glass-rockets”; finally, consolidation with “tissue like-sign” has a score of 3. The global LUS corresponds to the sum of each region’s score and ranges from 0 (all regions are well aerated) to 36 (all regions are consolidated).

Gynecologists and obstetricians, who already have pelvic ultrasound skills, usually require minimal training to recognize the main sonographic patterns of COVID-19 pulmonary involvement (26,27). In our COVID-19 dedicated area, a LU is routinely used by clinicians in charge of the patient who underwent a short training session with expert sonographers. If the patient is clinically unstable and LU is suggestive for worsening, a CT-scan is indicated and the patient is admitted to a high dependency unit (28,29).

We started enrolling our patients in an obstetric multicenter national study. A total of 40 COVID - 19 positive patients were admitted to our Department between March 2020 and December 2020, of which 38 were obstetric and 2 were gynecology patients. The majority had no respiratory symptoms, while only 3 required oxygen therapy to maintain SpO2 > 95%. No complications were observed and there was no cross infection between other patients or staff. We performed serial lung ultrasound examinations to monitor the patients’ conditions during the hospital stay.

Patient’s discharge

The data regarding COVID-19 patient’s admission and discharge are shared onto a national platform belonging to the Italian Healthcare Institute (30). Before discharge, the Unique Point of Access (UPA) organization that provides home support to patients, must be informed. UPA will inspect the patient’s home and decide if the place is suitable for proper isolation avoiding contact with housemates. If adequate, an ambulance transport home is arranged.

The Physician Response Unit in collaboration with the regional healthcare facilities covers the majority of the out of hospital visits for COVID-19 patients and follows up those who have been recently discharged. By using handheld ultrasound devices, doctors can perform scans along with complete patient’s assessment, evaluating their clinical progress or worsening that require hospitalization. If an admission from home or from another hospital is required a pre-alert call to our Obstetric Department is made in order to set the appropriate route and prevent healthcare workers and patients’ cross-contamination.

Conclusion

Due to the rapid spread of SARS-CoV-2 virus, our Department has been daily involved in logistic and clinical organization issues. Our priority is to ensure continuous care of SARS-CoV-2 positive patients while maintaining a safe environment for healthcare providers and those affected by other obstetric conditions. In order to contain contamination, we highly recommend securing different routes for patients even when a reduction in COVID-19 cases is observed. Daily meetings are necessary to update the whole team of consultants and trainees working in the unit and they can be safely run by videoconference. Simulations of emergency scenarios are also essential to address successes and implement weaknesses of the system.

Appendix

graphic file with name ACTA-93-217-g005.jpg

graphic file with name ACTA-93-217-g006.jpg

graphic file with name ACTA-93-217-g007.jpg

Conflict of Interest:

Each author declares that he or she has no commercial associations (e.g. consultancies, stock ownership, equity interest, patent/licensing arrangement etc.) that might pose a conflict of interest in connection with the submitted article

References

  1. Poon LC, Yang H, Lee JCS, et al. ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals. Ultrasound Obstet Gynecol. 2020 May;55(5):700–708. doi: 10.1002/uog.22013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol. 2015;1282:1–23. doi: 10.1007/978-1-4939-2438-7_1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Schwartz DA, Graham AL. Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections. Viruses. 2020 Feb 10;12(2):194. doi: 10.3390/v12020194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chua M, Lee J, Sulaiman S, Tan HK. From the frontline of COVID-19 - how prepared are we as obstetricians? A commentary. BJOG. 2020 Jun;127(7):786–788. doi: 10.1111/1471-0528.16192. doi: 10.1111/1471-0528.16192. Epub 2020 Mar 22. PMID: 32131142. [DOI] [PubMed] [Google Scholar]
  5. Yang S, Cao P, Du P, et al. Early estimation of the case fatality rate of COVID-19 in mainland China: a data-driven analysis. Ann Transl Med. 2020 Feb;8(4):128. doi: 10.21037/atm.2020.02.66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. WAPM (World Association of Perinatal Medicine) Working Group on COVID-19. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection. Ultrasound Obstet Gynecol. 2021 Feb;57(2):232–241. doi: 10.1002/uog.23107. doi: 10.1002/uog.23107. Epub 2021 Jan 21. PMID: 32926494. [DOI] [PubMed] [Google Scholar]
  7. Di Mascio D, Sen C, Saccone G, et al. Risk factors associated with adverse fetal outcomes in pregnancies affected by Coronavirus disease 2019 (COVID-19): a secondary analysis of the WAPM study on COVID-19. J Perinat Med. 2020 Nov 26;48(9):950–958. doi: 10.1515/jpm-2020-0355. doi: 10.1515/jpm-2020-0355. PMID: 32975205. [DOI] [PubMed] [Google Scholar]
  8. Franchi M, Del Piccolo L, Bosco M, et al. COVID-19 and mental health in the obstetric population: a lesson from a case of puerperal psychosis. Minerva Ginecol. 2020 Oct;72(5):355–357. doi: 10.23736/S0026-4784.20.04606-7. doi: 10.23736/S0026-4784.20.04606-7. Epub 2020 Jul 28. PMID: 32720801. [DOI] [PubMed] [Google Scholar]
  9. Driul L, Meroi F, Sala A, et al. Vaginal delivery in a patient with severe aortic stenosis under epidural analgesia, a case report. Cardiovasc Ultrasound. 2020 Nov 2;18(1):43. doi: 10.1186/s12947-020-00226-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Franchi M, Bosco M, Garzon G, et al. Management of obstetrics and gynecological patients with COVID-19. Italian JOG. 2020 March;32(1):6–19. doi: 10.36129/jog.32.01.01. [Google Scholar]
  11. Franchi M, Bosco M, Barbieri B, et al. Prevalence of SARS-CoV-2 infection in the obstetric population before the hospital admission. Minerva Ginecol. 2020 Dec;72(6):429–430. doi: 10.23736/S0026-4784.20.04654-7. doi: 10.23736/S0026-4784.20.04654-7. Epub 2020 Sep 24. PMID: 32969632. [DOI] [PubMed] [Google Scholar]
  12. Soldati G, Smargiassi A, Inchingolo R, et al. Proposal for International Standardization of the Use of Lung Ultrasound for Patients With COVID-19: A Simple, Quantitative, Reproducible Method. J Ultrasound Med. 2020 Jul;39(7):1413–1419. doi: 10.1002/jum.15285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Vetrugno L, Bove T, Orso D, et al. Our Italian experience using lung ultrasound for identification, grading and serial follow-up of severity of lung involvement for management of patients with COVID-19. Echocardiography. 2020 Apr;37(4):625–627. doi: 10.1111/echo.14664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Jackson K, Butler R, Aujayeb A. Lung ultrasound in the COVID-19 pandemic Postgraduate Medical Journal Published Online First: 07 September 2020. doi: 10.1136/postgradmedj-2020-138137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Youssef A, Cavalera M, Azzarone C, et al. The use of lung ultrasound during the COVID-19 pandemic: A narrative review with specific focus on its role in pregnancy. J Popul Ther Clin Pharmacol. 2020 Oct 15;27(S Pt 1):e64–e75. doi: 10.15586/jptcp.v27iSP1.743. [DOI] [PubMed] [Google Scholar]
  16. Alzahrani SA, Al-Salamah MA, Al-Madani WH, Elbarbary MA. Systematic review and meta-analysis for the use of ultrasound versus radiology in diagnosing pneumonia. Crit Ultrasound J. 2017 Dec;9(1):6. doi: 10.1186/s13089-017-0059-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Chavez MA, Shams N, Ellington LE, et al. Lung ultrasound for the diagnosis of pneumonia in adults: a systematic review and meta-analysis. Respir Res. 2014 Apr 23;15(1):50. doi: 10.1186/1465-9921-15-50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Orso D, Guglielmo N, Copetti R. Lung ultrasound in diagnosing pneumonia in the emergency department: a systematic review and meta-analysis. Eur J Emerg Med. 2018 Oct;25(5):312–321. doi: 10.1097/MEJ.0000000000000517. [DOI] [PubMed] [Google Scholar]
  19. Moro F, Buonsenso D, Moruzzi MC, et al. How to perform lung ultrasound in pregnant women with suspected COVID-19. Ultrasound Obstet Gynecol. 2020 May;55(5):593–598. doi: 10.1002/uog.22028. [DOI] [PubMed] [Google Scholar]
  20. Inchingolo R, Smargiassi A, Moro F, et al. The diagnosis of pneumonia in a pregnant woman with coronavirus disease 2019 using maternal lung ultrasound. Am J Obstet Gynecol. 2020 Jul;223(1):9–11. doi: 10.1016/j.ajog.2020.04.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Volpicelli G, Lamorte A, Villén T. What’s new in lung ultrasound during the COVID-19 pandemic. Intensive Care Med. 2020 Jul;46(7):1445–1448. doi: 10.1007/s00134-020-06048-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Xiao AT, Tong YX, Zhang S. False negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence. J Med Virol. 2020 Apr 9 doi: 10.1002/jmv.25855. 10.1002/jmv.25855. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Guarracino F, Vetrugno L, Forfori F, et al. Lung, Heart, Vascular, and Diaphragm Ultrasound Examination of COVID-19 Patients: A Comprehensive Approach. J Cardiothorac Vasc Anesth. 2020 Jun 11 doi: 10.1053/j.jvca.2020.06.013. S1053-0770(20)30519-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Lichter Y, Topilsky Y, Taieb P, et al. Lung ultrasound predicts clinical course and outcomes in COVID-19 patients. Intensive Care Med. 2020 Oct;46(10):1873–1883. doi: 10.1007/s00134-020-06212-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Buonsenso D, Raffaelli F, Tamburrini E, et al. Clinical role of lung ultrasound for diagnosis and monitoring of COVID-19 pneumonia in pregnant women. Ultrasound Obstet Gynecol. 2020 Jul;56(1):106–109. doi: 10.1002/uog.22055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Buonsenso D, Moro F, Inchingolo R, et al. Effectiveness of rapid lung ultrasound training program for gynecologists and obstetricians managing pregnant women with suspected COVID-19. Ultrasound Obstet Gynecol. 2020 Jul;56(1):110–111. doi: 10.1002/uog.22066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Kalafat E, Yaprak E, Cinar G, et al. Lung ultrasound and computed tomographic findings in pregnant woman with COVID-19. Ultrasound Obstet Gynecol. 2020 Jun;55(6):835–837. doi: 10.1002/uog.22034. [DOI] [PubMed] [Google Scholar]
  28. Vetrugno L, Baciarello M, Bignami E, et al. The “pandemic” increase in lung ultrasound use in response to Covid-19: can we complement computed tomography findings? A narrative review. Ultrasound J. 2020 Aug 17;12(1):39. doi: 10.1186/s13089-020-00185-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Brogi E, Bignami E, Sidoti A, et al. Could the use of bedside lung ultrasound reduce the number of chest x-rays in the intensive care unit? Cardiovasc Ultrasound. 2017 Sep 13;15(1):23. doi: 10.1186/s12947-017-0113-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Maraschini A, Corsi E, Salvatore MA. Donati S and the ItOSS COVID-19 Working Group, Coronavirus and birth in Italy: results of a national population-based cohort study. Ann Ist Super Sanità. 2020;56(3):378–389. doi: 10.4415/ANN_20_03_17. [DOI] [PubMed] [Google Scholar]

Articles from Acta Bio Medica : Atenei Parmensis are provided here courtesy of Mattioli 1885

RESOURCES